Technology | 2019.05.02
Nuvaira Receives French Innovation Funding for AIRFLOW-3 Pivotal Trial
Novel program provides reimbursement for TLD therapy in France MINNEAPOLIS, May 2, 2019 /PRNewswire/ -- Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, has received acceptance from the Haute Autorité de Santé (HAS, the French health technology...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]3-pivotal-trial-300841034.html
